SPT-300 for anxiety disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 19 Jun 2025: Trial started, NCT07065240
  2. 15 Jul 2025: Trial registered, NCT07065240

The trials

NCT07065240: A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

State
Under way
Phase
Phase 2
People
360 planned
Started
19 Jun 2025
Primary completion
Mar 2027
Arms
SPT-300
Results
None posted
  1. 19 Jun 2025: Trial started
  2. 15 Jul 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.